It's time for a randomized trial to evaluate the effect of statins on outcomes in men with prostate cancer undergoing treatment, say experts in the field.
The calls for a prospective trial have been prompted by retrospective observational trials that have shown a significant reduction in the risk for biochemical recurrence in men treated for the disease who were also taking statins. Two such studies have been published recently.
Žádné komentáře:
Okomentovat
Poznámka: Komentáře mohou přidávat pouze členové tohoto blogu.